
FIP1L1‐PDGFRα p.T674I‐D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1‐PDGFRα Positive Leukemia
Author(s) -
Lierman Els,
Smits Sanne,
Appleby Niamh,
Conneally Eibhlin,
Michaux Lucienne,
Vandenberghe Peter
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000182
Subject(s) - imatinib , ponatinib , medicine , cancer research , nilotinib , imatinib mesylate , tyrosine kinase inhibitor , pdgfra , abl , tyrosine kinase , myeloid leukemia , dasatinib , leukemia , gist , cancer , receptor , stromal cell